1. Home
  2. ARWR vs KMT Comparison

ARWR vs KMT Comparison

Compare ARWR & KMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • KMT
  • Stock Information
  • Founded
  • ARWR 2003
  • KMT 1938
  • Country
  • ARWR United States
  • KMT United States
  • Employees
  • ARWR N/A
  • KMT N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • KMT Industrial Machinery/Components
  • Sector
  • ARWR Health Care
  • KMT Industrials
  • Exchange
  • ARWR Nasdaq
  • KMT Nasdaq
  • Market Cap
  • ARWR 1.8B
  • KMT 1.6B
  • IPO Year
  • ARWR 1993
  • KMT N/A
  • Fundamental
  • Price
  • ARWR $16.36
  • KMT $21.52
  • Analyst Decision
  • ARWR Buy
  • KMT Hold
  • Analyst Count
  • ARWR 10
  • KMT 5
  • Target Price
  • ARWR $42.13
  • KMT $25.80
  • AVG Volume (30 Days)
  • ARWR 1.9M
  • KMT 968.4K
  • Earning Date
  • ARWR 05-12-2025
  • KMT 05-07-2025
  • Dividend Yield
  • ARWR N/A
  • KMT 3.72%
  • EPS Growth
  • ARWR N/A
  • KMT 2.33
  • EPS
  • ARWR N/A
  • KMT 1.38
  • Revenue
  • ARWR $545,209,000.00
  • KMT $1,993,706,000.00
  • Revenue This Year
  • ARWR $4,380.43
  • KMT N/A
  • Revenue Next Year
  • ARWR $66.56
  • KMT $1.80
  • P/E Ratio
  • ARWR N/A
  • KMT $15.57
  • Revenue Growth
  • ARWR 1436.97
  • KMT N/A
  • 52 Week Low
  • ARWR $9.57
  • KMT $17.30
  • 52 Week High
  • ARWR $30.41
  • KMT $32.18
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 59.58
  • KMT 55.64
  • Support Level
  • ARWR $14.92
  • KMT $20.79
  • Resistance Level
  • ARWR $17.19
  • KMT $21.91
  • Average True Range (ATR)
  • ARWR 0.95
  • KMT 0.47
  • MACD
  • ARWR 0.11
  • KMT -0.00
  • Stochastic Oscillator
  • ARWR 70.29
  • KMT 47.40

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

About KMT Kennametal Inc.

Kennametal Inc is a manufacturer of metalworking tools and wear-resistant engineered components and coatings. The company operates in two business segments; Metal Cutting and Infrastructure. It generates maximum revenue from the Metal Cutting segment. The Metal Cutting segment develops and manufactures high-performance tooling and metal cutting products and services and offers an assortment of standard and custom metal cutting solutions to diverse end markets, including aerospace, general engineering, energy, and transportation. Geographically, it derives maximum revenue from the United States and the rest from Germany, China, Canada, India, Italy, and other countries.

Share on Social Networks: